ECSS
BIIB icon

Eurizon Capital SGR SpA’s Biogen BIIB Stock Holding History

Eurizon Capital SGR SpA’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2M Sell
102,594
-26,610
-21% -$5.09M 0.06% 233
2026
Q1 		$23.7M Sell
129,204
-1,609
-1% -$296K 0.07% 222
2025
Q4 		$23M Buy
+130,813
New +$21.4M 0.07% 198

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Eurizon Capital SGR SpA's BIIB Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Biogen (BIIB) stake by 21% in Q2 2026, selling an estimated $5.09M and leaving 102,594 shares worth $22.2M. The position accounts for 0.06% of the portfolio, ranked #233.

Eurizon Capital SGR SpA first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. The position peaked at $23.7M in Q1 2026. 1,035 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Eurizon Capital SGR SpA held 102,594 shares of Biogen worth $22.2M as of Q2 2026.
  • Eurizon Capital SGR SpA sold 26,610 Biogen shares in Q2 2026, an estimated $5.09M.
  • Biogen made up 0.06% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #233 holding.
  • Eurizon Capital SGR SpA first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Biogen position peaked at $23.7M in Q1 2026.
  • 1,035 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.